List of Chapters/Sections(Table Of Content)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid Multiplex Assay
1.2 Key Market Segments
1.2.1 Nucleic Acid Multiplex Assay Segment by Type
1.2.2 Nucleic Acid Multiplex Assay Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Acid Multiplex Assay Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Multiplex Assay Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nucleic Acid Multiplex Assay Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Acid Multiplex Assay Market Competitive Landscape
3.1 Global Nucleic Acid Multiplex Assay Sales by Manufacturers (2019-2024)
3.2 Global Nucleic Acid Multiplex Assay Revenue Market Share by Manufacturers (2019-2024)
3.3 Nucleic Acid Multiplex Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nucleic Acid Multiplex Assay Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nucleic Acid Multiplex Assay Sales Sites, Area Served, Product Type
3.6 Nucleic Acid Multiplex Assay Market Competitive Situation and Trends
3.6.1 Nucleic Acid Multiplex Assay Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nucleic Acid Multiplex Assay Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid Multiplex Assay Industry Chain Analysis
4.1 Nucleic Acid Multiplex Assay Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid Multiplex Assay Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nucleic Acid Multiplex Assay Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Multiplex Assay Sales Market Share by Type (2019-2024)
6.3 Global Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
6.4 Global Nucleic Acid Multiplex Assay Price by Type (2019-2024)
7 Nucleic Acid Multiplex Assay Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Multiplex Assay Market Sales by Application (2019-2024)
7.3 Global Nucleic Acid Multiplex Assay Market Size (M USD) by Application (2019-2024)
7.4 Global Nucleic Acid Multiplex Assay Sales Growth Rate by Application (2019-2024)
8 Nucleic Acid Multiplex Assay Market Segmentation by Region
8.1 Global Nucleic Acid Multiplex Assay Sales by Region
8.1.1 Global Nucleic Acid Multiplex Assay Sales by Region
8.1.2 Global Nucleic Acid Multiplex Assay Sales Market Share by Region
8.2 North America
8.2.1 North America Nucleic Acid Multiplex Assay Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nucleic Acid Multiplex Assay Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nucleic Acid Multiplex Assay Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nucleic Acid Multiplex Assay Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nucleic Acid Multiplex Assay Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Luminex Corporation (US)
9.1.1 Luminex Corporation (US) Nucleic Acid Multiplex Assay Basic Information
9.1.2 Luminex Corporation (US) Nucleic Acid Multiplex Assay Product Overview
9.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Product Market Performance
9.1.4 Luminex Corporation (US) Business Overview
9.1.5 Luminex Corporation (US) Nucleic Acid Multiplex Assay SWOT Analysis
9.1.6 Luminex Corporation (US) Recent Developments
9.2 Thermo Fisher Scientific Inc. (US)
9.2.1 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Basic Information
9.2.2 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product Overview
9.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product Market Performance
9.2.4 Thermo Fisher Scientific Inc. (US) Business Overview
9.2.5 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay SWOT Analysis
9.2.6 Thermo Fisher Scientific Inc. (US) Recent Developments
9.3 Illumina, Inc (US)
9.3.1 Illumina, Inc (US) Nucleic Acid Multiplex Assay Basic Information
9.3.2 Illumina, Inc (US) Nucleic Acid Multiplex Assay Product Overview
9.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Product Market Performance
9.3.4 Illumina, Inc (US) Nucleic Acid Multiplex Assay SWOT Analysis
9.3.5 Illumina, Inc (US) Business Overview
9.3.6 Illumina, Inc (US) Recent Developments
9.4 Bio-Rad Laboratories, Inc. (US)
9.4.1 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Basic Information
9.4.2 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product Overview
9.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product Market Performance
9.4.4 Bio-Rad Laboratories, Inc. (US) Business Overview
9.4.5 Bio-Rad Laboratories, Inc. (US) Recent Developments
9.5 Qiagen N.V. (Netherlands)
9.5.1 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Basic Information
9.5.2 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product Overview
9.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product Market Performance
9.5.4 Qiagen N.V. (Netherlands) Business Overview
9.5.5 Qiagen N.V. (Netherlands) Recent Developments
9.6 Abcam plc (UK)
9.6.1 Abcam plc (UK) Nucleic Acid Multiplex Assay Basic Information
9.6.2 Abcam plc (UK) Nucleic Acid Multiplex Assay Product Overview
9.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Product Market Performance
9.6.4 Abcam plc (UK) Business Overview
9.6.5 Abcam plc (UK) Recent Developments
9.7 Becton, Dickinson and Company (US)
9.7.1 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Basic Information
9.7.2 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product Overview
9.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product Market Performance
9.7.4 Becton, Dickinson and Company (US) Business Overview
9.7.5 Becton, Dickinson and Company (US) Recent Developments
9.8 Merck KGaA (Germany)
9.8.1 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Basic Information
9.8.2 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product Overview
9.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product Market Performance
9.8.4 Merck KGaA (Germany) Business Overview
9.8.5 Merck KGaA (Germany) Recent Developments
9.9 Agilent Technologies, Inc. (US)
9.9.1 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Basic Information
9.9.2 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product Overview
9.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product Market Performance
9.9.4 Agilent Technologies, Inc. (US) Business Overview
9.9.5 Agilent Technologies, Inc. (US) Recent Developments
9.10 Meso Scale Diagnostics (US)
9.10.1 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Basic Information
9.10.2 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product Overview
9.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product Market Performance
9.10.4 Meso Scale Diagnostics (US) Business Overview
9.10.5 Meso Scale Diagnostics (US) Recent Developments
9.11 Randox Laboratories (UK)
9.11.1 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Basic Information
9.11.2 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product Overview
9.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product Market Performance
9.11.4 Randox Laboratories (UK) Business Overview
9.11.5 Randox Laboratories (UK) Recent Developments
9.12 Quanterix (US)
9.12.1 Quanterix (US) Nucleic Acid Multiplex Assay Basic Information
9.12.2 Quanterix (US) Nucleic Acid Multiplex Assay Product Overview
9.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Product Market Performance
9.12.4 Quanterix (US) Business Overview
9.12.5 Quanterix (US) Recent Developments
9.13 Bio-Techne Corporation (US)
9.13.1 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Basic Information
9.13.2 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product Overview
9.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product Market Performance
9.13.4 Bio-Techne Corporation (US) Business Overview
9.13.5 Bio-Techne Corporation (US) Recent Developments
9.14 Olink (Sweden)
9.14.1 Olink (Sweden) Nucleic Acid Multiplex Assay Basic Information
9.14.2 Olink (Sweden) Nucleic Acid Multiplex Assay Product Overview
9.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Product Market Performance
9.14.4 Olink (Sweden) Business Overview
9.14.5 Olink (Sweden) Recent Developments
9.15 DiaSorin S.p.A. (Italy)
9.15.1 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Basic Information
9.15.2 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product Overview
9.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product Market Performance
9.15.4 DiaSorin S.p.A. (Italy) Business Overview
9.15.5 DiaSorin S.p.A. (Italy) Recent Developments
9.16 Seegene (South Korea)
9.16.1 Seegene (South Korea) Nucleic Acid Multiplex Assay Basic Information
9.16.2 Seegene (South Korea) Nucleic Acid Multiplex Assay Product Overview
9.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Product Market Performance
9.16.4 Seegene (South Korea) Business Overview
9.16.5 Seegene (South Korea) Recent Developments
9.17 Promega Corporation (US)
9.17.1 Promega Corporation (US) Nucleic Acid Multiplex Assay Basic Information
9.17.2 Promega Corporation (US) Nucleic Acid Multiplex Assay Product Overview
9.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Product Market Performance
9.17.4 Promega Corporation (US) Business Overview
9.17.5 Promega Corporation (US) Recent Developments
9.18 Siemens Healthineers (Germany)
9.18.1 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Basic Information
9.18.2 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product Overview
9.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product Market Performance
9.18.4 Siemens Healthineers (Germany) Business Overview
9.18.5 Siemens Healthineers (Germany) Recent Developments
9.19 PerkinElmer, Inc. (US)
9.19.1 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Basic Information
9.19.2 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product Overview
9.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product Market Performance
9.19.4 PerkinElmer, Inc. (US) Business Overview
9.19.5 PerkinElmer, Inc. (US) Recent Developments
9.20 Shimadzu Biotech (Japan)
9.20.1 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Basic Information
9.20.2 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product Overview
9.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product Market Performance
9.20.4 Shimadzu Biotech (Japan) Business Overview
9.20.5 Shimadzu Biotech (Japan) Recent Developments
9.21 Antigenix America, Inc. (US)
9.21.1 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Basic Information
9.21.2 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product Overview
9.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product Market Performance
9.21.4 Antigenix America, Inc. (US) Business Overview
9.21.5 Antigenix America, Inc. (US) Recent Developments
9.22 Enzo Life Sciences, Inc. (US)
9.22.1 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Basic Information
9.22.2 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product Overview
9.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product Market Performance
9.22.4 Enzo Life Sciences, Inc. (US) Business Overview
9.22.5 Enzo Life Sciences, Inc. (US) Recent Developments
9.23 Boster Biological Technology (US)
9.23.1 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Basic Information
9.23.2 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product Overview
9.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product Market Performance
9.23.4 Boster Biological Technology (US) Business Overview
9.23.5 Boster Biological Technology (US) Recent Developments
9.24 AYOXXA Biosystems GmbH (Germany)
9.24.1 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Basic Information
9.24.2 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product Overview
9.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product Market Performance
9.24.4 AYOXXA Biosystems GmbH (Germany) Business Overview
9.24.5 AYOXXA Biosystems GmbH (Germany) Recent Developments
9.25 Cayman Chemical Company (US)
9.25.1 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Basic Information
9.25.2 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product Overview
9.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product Market Performance
9.25.4 Cayman Chemical Company (US) Business Overview
9.25.5 Cayman Chemical Company (US) Recent Developments
10 Nucleic Acid Multiplex Assay Market Forecast by Region
10.1 Global Nucleic Acid Multiplex Assay Market Size Forecast
10.2 Global Nucleic Acid Multiplex Assay Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nucleic Acid Multiplex Assay Market Size Forecast by Country
10.2.3 Asia Pacific Nucleic Acid Multiplex Assay Market Size Forecast by Region
10.2.4 South America Nucleic Acid Multiplex Assay Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nucleic Acid Multiplex Assay by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nucleic Acid Multiplex Assay Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nucleic Acid Multiplex Assay by Type (2025-2030)
11.1.2 Global Nucleic Acid Multiplex Assay Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nucleic Acid Multiplex Assay by Type (2025-2030)
11.2 Global Nucleic Acid Multiplex Assay Market Forecast by Application (2025-2030)
11.2.1 Global Nucleic Acid Multiplex Assay Sales (K Units) Forecast by Application
11.2.2 Global Nucleic Acid Multiplex Assay Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
